Delaying risk-reducing removal of ovaries and fallopian tubes until age 40–45 is reasonable for women carrying BRCA2 mutation (BRCA2m) because the average age of ovarian cancer onset is 8–10 years later than in BRCA1m [2]. This evidence concerns the gene BRCA2 and ovarian carcinoma.